Revolution Medicines Inc. (RVMD)
NASDAQ: RVMD
· Real-Time Price · USD
37.16
-2.61 (-6.56%)
At close: May 27, 2025, 3:15 PM
-6.56% (1D)
| Bid | 37.06 |
| Market Cap | 6.92B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -697.51M |
| EPS (ttm) | -4.01 |
| PE Ratio (ttm) | -9.27 |
| Forward PE | -7.82 |
| Analyst | Buy |
| Ask | 37.25 |
| Volume | 2,227,170 |
| Avg. Volume (20D) | 1,792,778 |
| Open | 40.00 |
| Previous Close | 39.77 |
| Day's Range | 36.57 - 40.00 |
| 52-Week Range | 29.17 - 62.40 |
| Beta | 1.11 |
About RVMD
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RVMD
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for RVMD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 weeks ago
+11.29%
Revolution Medicines shares are trading higher aft...
Unlock content with
Pro Subscription
2 weeks ago
+0.59%
Revolution Medicines shares are trading higher. The company reported Q1 financial results.
2 weeks ago · seekingalpha.com
Revolution Medicines, Inc. (RVMD) Q1 2025 Earnings Call TranscriptRevolution Medicines, Inc. (NASDAQ:RVMD ) Q1 2025 Earnings Conference Call May 7, 2025 4:30 PM ET Company Participants Ryan Asay - Senior Vice President-Corporate Affairs Mark Goldsmith - Chairman and...
2 months ago · seekingalpha.com
Revolution Medicines, Inc. (RVMD) Q4 2024 Earnings Call TranscriptRevolution Medicines, Inc. (NASDAQ:RVMD ) Q4 2024 Earnings Conference Call February 26, 2025 4:30 PM ET Company Participants Ryan Asay - Senior Vice President-Corporate Affairs Mark Goldsmith - Chairm...